GENELINK INC
Healthcare · Services-Medical Laboratories · PA · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | FY10 | |
|---|---|---|---|
| Revenue | $2.1M | $4.7M | $7.8M |
| Operating income | −$3.5M | −$3.6M | −$2.4M |
| Net income | −$3.1M | −$3.8M | −$2.6M |
| Total assets | $1.5M | $2.8M | $1.7M |
| Total liabilities | $4.1M | $4.3M | $2.5M |
| Equity | −$2.7M | −$1.5M | −$789,857 |
| EPS (diluted) | — | — | — |
| Shares out. | 202.9M | 200.6M | 151.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- −162.4%
- Net margin
- −142.9%
- Return on equity
- 114.7%
- Return on assets
- −209.8%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 282.9%
- Debt / equity
- —
- Book value / share
- $-0.01
- Revenue growth (YoY)
- −54.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2012- Altman Z″ (distress)
- -83.39distress
- Accruals / assets
- −45.9%clean
- Beneish M-Score
- -4.63normal
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2014
- NT 10-Qmissed a reporting deadline ↗May 15, 2012
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2012
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2011
- NT 10-Qmissed a reporting deadline ↗May 15, 2009
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2008
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivershipApr 22, 2014
- Director / officer changeNov 14, 2013
- Director / officer changeJul 8, 2013
- Shareholder vote · Other material eventJun 12, 2013
- Director / officer changeFeb 12, 2013
- Director / officer changeJul 17, 2012
- Prior financials not reliable (restatement)May 10, 2012
- Changed auditorApr 27, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFeb 25, 2015
- 8-KApr 22, 2014
- NT 10-KApr 1, 2014
- UPLOADDec 20, 2013
- 10-K/AGENELINK 10-K/A 12-31-2012Dec 17, 2013
- 10-K/AGENELINK INC 10-K A NO 1 12-31-2012Nov 27, 2013
- 8-KGENELINK, INC 8-K 11-14-2013Nov 14, 2013
- 10-QGENELINK INC 10-Q 9-30-2013Nov 14, 2013
- CORRESPNov 13, 2013
- CORRESPOct 29, 2013
- UPLOADOct 15, 2013
- CORRESPSep 30, 2013
- UPLOADSep 16, 2013
- CORRESPSep 5, 2013
- CORRESPAug 22, 2013
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.